LEXARIA BIOSCIENCE CORP. Other Noncash Income (Expense)
LEXARIA BIOSCIENCE CORP. (LEXX) reported Other Noncash Income (Expense) of -$15.92 thousand for the 3-month period ending 2024-11-30, per its 10-Q filed 2025-01-10.
Financial Statements › Cash Flow › Operating Activities
us-gaap:OtherNoncashIncomeExpense · last filed 2025-01-10
- LEXARIA BIOSCIENCE CORP. other noncash income (expense) for the quarter ending 2024-11-30 was -$15.92K.
- LEXARIA BIOSCIENCE CORP. other noncash income (expense) for the quarter ending 2024-08-31 was $16.49K.
- LEXARIA BIOSCIENCE CORP. other noncash income (expense) for the quarter ending 2024-05-31 was -$41.39K, a 339.28% decline year-over-year.
- LEXARIA BIOSCIENCE CORP. other noncash income (expense) for the quarter ending 2024-02-29 was $15.27K, a 17.60% increase year-over-year.
- LEXARIA BIOSCIENCE CORP. other noncash income (expense) for fiscal 2024 was -$55.52K.
- LEXARIA BIOSCIENCE CORP. other noncash income (expense) for fiscal 2023 was -$178.50K.
| Period end | Other Noncash Income (Expense) 3 month | Other Noncash Income (Expense) 6 month | Other Noncash Income (Expense) 6 month as first filed | Other Noncash Income (Expense) 9 month | Other Noncash Income (Expense) 9 month as first filed | Other Noncash Income (Expense) 12 month |
|---|---|---|---|---|---|---|
| 2024-11-30 | -$15.92K 10-Q · filed 2025-01-10 | $572.00 derived: sum of 2 quarters · filed 2025-01-10 | -$40.82K derived: sum of 3 quarters · filed 2025-01-10 | -$25.55K derived: sum of 4 quarters · filed 2025-01-10 | ||
| 2024-08-31 | $16.49K derived: 10-K 12 month − 10-Q 9 month · filed 2024-11-26 | -$24.90K derived: sum of 2 quarters · filed 2024-11-26 | -$9.63K derived: sum of 3 quarters · filed 2024-11-26 | -$55.52K 10-K · filed 2024-11-26 | ||
| 2024-05-31 | -$41.39K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-07-12 | -$26.12K derived: sum of 2 quarters · filed 2024-07-12 | -$72.02K 10-Q · filed 2024-07-12 | -$206.92K derived: sum of 4 quarters · filed 2025-01-10 | ||
| 2024-02-29 | $15.27K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-04-09 | -$30.62K 10-Q · filed 2024-04-09 | -$165.53K derived: sum of 3 quarters · filed 2025-01-10 | -$148.23K derived: sum of 4 quarters · filed 2025-01-10 | ||
| 2023-11-30 | -$45.90K 10-Q · filed 2025-01-10 | -$180.80K derived: sum of 2 quarters · filed 2025-01-10 | -$163.50K derived: sum of 3 quarters · filed 2025-01-10 | -$150.51K derived: sum of 4 quarters · filed 2025-01-10 | ||
| 2023-08-31 | -$134.90K derived: 10-K 12 month − 10-Q 9 month · filed 2024-11-26 | -$117.60K derived: sum of 2 quarters · filed 2024-11-26 | -$104.62K derived: sum of 3 quarters · filed 2024-11-26 | -$178.50K 10-K · filed 2024-11-26 | ||
| 2023-05-31 | $17.30K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-07-12 | $30.29K derived: sum of 2 quarters · filed 2024-07-12 | -$43.60K 10-Q · filed 2024-07-12 | |||
| 2023-02-28 | $12.99K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-04-09 | -$60.90K 10-Q · filed 2024-04-09 | ||||
| 2022-11-30 | -$73.89K 10-Q · filed 2024-01-12 | |||||
| 2017-05-31 | -$292.29K 10-Q · filed 2017-07-14 | |||||
| 2017-02-28 | -$280.29K 10-Q · filed 2017-04-14 | |||||
| 2016-05-31 | -$55.75K 10-Q · filed 2017-07-14 | -$56.22K 10-Q · filed 2016-07-13 | ||||
| 2016-02-29 | -$9.14K 10-Q · filed 2017-04-14 | -$9.45K 10-Q · filed 2016-04-13 | ||||
| 2015-11-30 | $0.00 10-Q · filed 2016-01-08 | |||||
| 2015-05-31 | -$48.04K 10-Q · filed 2016-07-13 | |||||
| 2015-02-28 | -$48.04K 10-Q · filed 2016-04-13 | |||||
| 2014-11-30 | -$48.04K 10-Q · filed 2016-01-08 | |||||
| 2014-05-31 | $23.50K 10-Q · filed 2015-07-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |